Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

Answer ALS Foundation, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium, Project MinE ALS Sequencing Consortium, ITALSGEN consortium, Genomic Translation for ALS Care (GTAC) Consortium, ALS Sequencing Consortium, NYGC ALS Consortium, Claudia Caponnetto

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS. Using a large-scale genome-wide association study and exome sequencing, we identified KIF5A as a novel gene associated with ALS. Our data broaden the phenotype resulting from mutations in KIF5A and highlight the importance of cytoskeletal defects in the pathogenesis of ALS.

Original languageEnglish
Pages (from-to)1268-1283.e6
JournalNeuron
Volume97
Issue number6
DOIs
Publication statusPublished - Mar 21 2018

Fingerprint

Kinesin
Genome
Mutation
Genes
Genome-Wide Association Study
Hereditary Spastic Paraplegia
Exome
Phenotype
Neurodegenerative Diseases
Tooth
Survival

Keywords

  • ALS
  • axonal transport
  • cargo
  • GWAS
  • KIF5A
  • WES
  • WGS

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Answer ALS Foundation, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium, Project MinE ALS Sequencing Consortium, ITALSGEN consortium, ... Caponnetto, C. (2018). Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron, 97(6), 1268-1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. / Answer ALS Foundation; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium; SLAGEN Consortium; French ALS Consortium; Project MinE ALS Sequencing Consortium; ITALSGEN consortium; Genomic Translation for ALS Care (GTAC) Consortium; ALS Sequencing Consortium; NYGC ALS Consortium ; Caponnetto, Claudia.

In: Neuron, Vol. 97, No. 6, 21.03.2018, p. 1268-1283.e6.

Research output: Contribution to journalArticle

Answer ALS Foundation, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium, Project MinE ALS Sequencing Consortium, ITALSGEN consortium, Genomic Translation for ALS Care (GTAC) Consortium, ALS Sequencing Consortium, NYGC ALS Consortium & Caponnetto, C 2018, 'Genome-wide Analyses Identify KIF5A as a Novel ALS Gene', Neuron, vol. 97, no. 6, pp. 1268-1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027
Answer ALS Foundation, Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, SLAGEN Consortium, French ALS Consortium, Project MinE ALS Sequencing Consortium, ITALSGEN consortium et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018 Mar 21;97(6):1268-1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027
Answer ALS Foundation ; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium ; SLAGEN Consortium ; French ALS Consortium ; Project MinE ALS Sequencing Consortium ; ITALSGEN consortium ; Genomic Translation for ALS Care (GTAC) Consortium ; ALS Sequencing Consortium ; NYGC ALS Consortium ; Caponnetto, Claudia. / Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. In: Neuron. 2018 ; Vol. 97, No. 6. pp. 1268-1283.e6.
@article{d771d5bf32d542d8a59a3feeba12ee5d,
title = "Genome-wide Analyses Identify KIF5A as a Novel ALS Gene",
abstract = "To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS. Using a large-scale genome-wide association study and exome sequencing, we identified KIF5A as a novel gene associated with ALS. Our data broaden the phenotype resulting from mutations in KIF5A and highlight the importance of cytoskeletal defects in the pathogenesis of ALS.",
keywords = "ALS, axonal transport, cargo, GWAS, KIF5A, WES, WGS",
author = "{Answer ALS Foundation} and {Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium} and {SLAGEN Consortium} and {French ALS Consortium} and {Project MinE ALS Sequencing Consortium} and {ITALSGEN consortium} and {Genomic Translation for ALS Care (GTAC) Consortium} and {ALS Sequencing Consortium} and {NYGC ALS Consortium} and Aude Nicolas and Kenna, {Kevin P.} and Renton, {Alan E.} and Nicola Ticozzi and Faraz Faghri and Ruth Chia and Fabrizio Salvi and Ilaria Bartolomei and Gabriele Mora and Kalliopi Marinou and Riccardo Sideri and Nilo Riva and Paola Carrera and Paolo Volanti and Marco Luigetti and Fabrizio Pisano and Gabriele Mora and Nilo Riva and Paolo Volanti and Fabrizio Salvi and Vincenzo Silani and Nicola Ticozzi and Cinzia Gellera and Antonia Ratti and Franco Taroni and Giuseppe Lauria and Cinzia Tiloca and Comi, {Giacomo P.} and Cristina Cereda and Stefania Corti and Mauro Ceroni and Claudia Colombrita and Barbara Poletti and Luca Maderna and {Del Bo}, Roberto and Stella Gagliardi and Viviana Pensato and Barbara Castellotti and Giuseppe Lauria and Cinzia Tiloca and Comi, {Giacomo P.} and Cristina Cereda and Vincenzo Silani and Nicola Ticozzi and Franco Taroni and Antonia Ratti and Cinzia Gellera and Claudia Caponnetto",
year = "2018",
month = "3",
day = "21",
doi = "10.1016/j.neuron.2018.02.027",
language = "English",
volume = "97",
pages = "1268--1283.e6",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

AU - Answer ALS Foundation

AU - Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium

AU - SLAGEN Consortium

AU - French ALS Consortium

AU - Project MinE ALS Sequencing Consortium

AU - ITALSGEN consortium

AU - Genomic Translation for ALS Care (GTAC) Consortium

AU - ALS Sequencing Consortium

AU - NYGC ALS Consortium

AU - Nicolas, Aude

AU - Kenna, Kevin P.

AU - Renton, Alan E.

AU - Ticozzi, Nicola

AU - Faghri, Faraz

AU - Chia, Ruth

AU - Salvi, Fabrizio

AU - Bartolomei, Ilaria

AU - Mora, Gabriele

AU - Marinou, Kalliopi

AU - Sideri, Riccardo

AU - Riva, Nilo

AU - Carrera, Paola

AU - Volanti, Paolo

AU - Luigetti, Marco

AU - Pisano, Fabrizio

AU - Mora, Gabriele

AU - Riva, Nilo

AU - Volanti, Paolo

AU - Salvi, Fabrizio

AU - Silani, Vincenzo

AU - Ticozzi, Nicola

AU - Gellera, Cinzia

AU - Ratti, Antonia

AU - Taroni, Franco

AU - Lauria, Giuseppe

AU - Tiloca, Cinzia

AU - Comi, Giacomo P.

AU - Cereda, Cristina

AU - Corti, Stefania

AU - Ceroni, Mauro

AU - Colombrita, Claudia

AU - Poletti, Barbara

AU - Maderna, Luca

AU - Del Bo, Roberto

AU - Gagliardi, Stella

AU - Pensato, Viviana

AU - Castellotti, Barbara

AU - Lauria, Giuseppe

AU - Tiloca, Cinzia

AU - Comi, Giacomo P.

AU - Cereda, Cristina

AU - Silani, Vincenzo

AU - Ticozzi, Nicola

AU - Taroni, Franco

AU - Ratti, Antonia

AU - Gellera, Cinzia

AU - Caponnetto, Claudia

PY - 2018/3/21

Y1 - 2018/3/21

N2 - To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS. Using a large-scale genome-wide association study and exome sequencing, we identified KIF5A as a novel gene associated with ALS. Our data broaden the phenotype resulting from mutations in KIF5A and highlight the importance of cytoskeletal defects in the pathogenesis of ALS.

AB - To identify novel genes associated with ALS, we undertook two lines of investigation. We carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls. Independently, we performed a rare variant burden analysis comparing 1,138 index familial ALS cases and 19,494 controls. Through both approaches, we identified kinesin family member 5A (KIF5A) as a novel gene associated with ALS. Interestingly, mutations predominantly in the N-terminal motor domain of KIF5A are causative for two neurodegenerative diseases: hereditary spastic paraplegia (SPG10) and Charcot-Marie-Tooth type 2 (CMT2). In contrast, ALS-associated mutations are primarily located at the C-terminal cargo-binding tail domain and patients harboring loss-of-function mutations displayed an extended survival relative to typical ALS cases. Taken together, these results broaden the phenotype spectrum resulting from mutations in KIF5A and strengthen the role of cytoskeletal defects in the pathogenesis of ALS. Using a large-scale genome-wide association study and exome sequencing, we identified KIF5A as a novel gene associated with ALS. Our data broaden the phenotype resulting from mutations in KIF5A and highlight the importance of cytoskeletal defects in the pathogenesis of ALS.

KW - ALS

KW - axonal transport

KW - cargo

KW - GWAS

KW - KIF5A

KW - WES

KW - WGS

UR - http://www.scopus.com/inward/record.url?scp=85044172835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044172835&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2018.02.027

DO - 10.1016/j.neuron.2018.02.027

M3 - Article

AN - SCOPUS:85044172835

VL - 97

SP - 1268-1283.e6

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 6

ER -